1. Field of the Invention
The present invention relates generally to administration of medication. More specifically, the present invention relates to the administration of medication by a method and apparatus for facilitating inhalation of dry powder medicaments.
2. Related art
In the medical field, it is often desirable to administer various forms of medication to patients. Well known methods of introducing medication into the human body include the oral ingestion of capsules and tablets, intravenous injection through hypodermic needles, and numerous others. In one method, certain medications may be inhaled into a patient's respiratory tract and lungs through the nose or mouth. Certain of these medications, such as bronchodilators, corticosteroids, etc., for the treatment of asthma and other respiratory anomalies, may be aimed at the respiratory tract directly. Others are inhaled for purposes of systemic treatment, i.e. for treatment of any area of the body through absorption from the respiratory tract through the lung tissue, into the deep lungs, and into the bloodstream. Each of these medications comes in a variety of forms, including fluids, which are commonly administered as an aerosol vapor or mist, as well as solids. Inhalable solids typically take the form of fine, dry powders. Specialized devices, such as inhalers, are provided to assist the patient in directing these fine powder medications into the respiratory tract.
A variety of inhalers are known for the administration of dry powder medicaments. However, each of these inhalers suffers certain drawbacks. For example, U.S. Pat. No. 5,787,881 discloses an inhaler that is used with encapsulated dry powder medicaments. However, use of this device requires numerous steps and imposes a number of inconveniences on a user. For example, the medication capsules used with the device have an aperture formed therein prior to insertion into an opening in the inhaler. Therefore, there exists a danger that an amount of medication may be lost prior to or during insertion into the device. After insertion of the capsule, use of the device requires the additional step that a cover must be closed before the medication may be inhaled. Further inconveniences arise during periods of nonuse of the device. For example, because medication is not inserted into the device until just prior to use, the medication and the device may inadvertently become separated, and alone, each is useless. Furthermore, because the device is circular in shape, it is not as readily stored as a flatter device would be in locations such as wallet or pocket, for example.
The above inhaler and others which are known may be operated in a positive gas assisted manner, such as with a source of compressed air or other gas. These devices are inconvenient for a user in that the compressed gas source must be carried with the inhaler if medication is to be effectively administered. Also, these devices carry the additional danger that a pressurized container may become ruptured.
Propellant-free inhalers, which depend only on an inspiration by a user, are also known. One such device is disclosed in U.S. Pat. No. 5,575,280. This device houses in a storage chamber an amount of medication sufficient for administration of more than one dose. Just prior to each use, a notched wheel rotates to meter an amount of powder into a separate chamber for inhalation. However, if the medication does not properly fill such a notch, because of an air pocket, for example, an improper amount of medication may be administered following rotation of the wheel. This inaccuracy can potentially lead to ineffective treatment of an ailment, and thereby result in prolonged suffering by a patient.
Thus, there is a need in the art for an improved method and apparatus for inhalation of dry powder medicaments. What is needed is an inhaler having medication pre-stored therein, and which requires minimal steps by a user prior to use. Such a device would preferably come in a size and shape for portability and convenient storage by a user, and would be designed to avoid spillage or other events leading to inaccurate administration of medication, such that a proper dosage is administered each time such a device is used. The present invention, the description of which is fully set forth below, solves the need in the art for such improved methods and apparatus.
The present invention relates to a method and apparatus for facilitating inhalation of dry powder medicaments. In one aspect of the invention, an apparatus for inhaling powder is provided. The apparatus includes a casing that houses a powder chamber. The powder chamber is formed by a first wall that is coupled to the casing, and a second wall having a removable portion. At least one ventilation opening is defined in the casing to allow air to enter. The casing also includes a powder outlet opening to allow air and powder to exit from the casing.
In a further aspect of the present invention, another apparatus for inhaling powder is provided. The apparatus includes a casing having a first casing portion and a second casing portion. The casing portions are coupled such that they may slide with respect to each other. The casing contains a powder chamber, and has at least one ventilation opening to allow air to enter into the casing. The casing also includes a powder outlet opening. The powder chamber is configured such that sliding the first casing portion relative to the second casing portion causes the powder chamber to move from a closed position to an opened position. In the opened position, powder from the powder chamber can exit the device through the powder outlet opening.
In yet another aspect of the present invention, a method of dispensing powders by inhalation is provided. The method involves providing a powder inhalation device. The powder inhalation device includes a casing having a powder chamber that contains powder. A first wall that is coupled to the casing and a second wall having a removable portion define the powder chamber. At least one ventilation opening is defined in the casing to allow air to enter into the casing. The casing includes a powder outlet opening to allow powder to exit from the casing. The method further involves pulling a tether coupled to the removable portion of the second wall, thereby removing the removable portion and defining an opening in the second wall. A final aspect of the method involves inhaling the powder.
In still yet another aspect of the present invention, another method of dispensing powders by inhalation is provided. The method involves providing a powder inhalation device having a casing. The casing has a first casing portion and a second casing portion, with the casing portions being slidable with respect to each other. Defined in the casing is a powder chamber containing powder. The casing also includes a powder outlet opening and at least one ventilation opening to allow air to enter into the casing. The powder chamber is configured such that sliding the first casing portion relative to the second casing portion causes the powder chamber to move from a closed position to an opened position, allowing powder to exit the powder inhalation device through the powder outlet opening. The method further involves sliding the first casing portion relative to the second casing portion, thereby moving the powder chamber to the opened position. Finally, the method involves inhaling the powder.
Features and Advantages
One feature of the present invention is its compact and convenient size and shape. The dimensions of the inhaler render it ideal for storage in a pocket, or wallet or purse of a patient, with such items as identification or credit cards.
Another advantageous feature of the present invention is the accuracy of medicament dosage delivered thereby. Since only one dosage of medication is present in the inhaler during each use, the possibility of overdose is eliminated, and the medicament need not be metered prior to delivery. A patient may simply inhale all medicament present in the device.
The present invention also possesses the advantage that the medicament is stored inside the inhaler. The inhaler advantageously may be made from a material having a desiccant integral to it, or otherwise include a desiccant, to protect the medicament from moisture during storage. No capsules or other storage units need be carried other than the inhaler itself. In addition, the medicament is sealed securely inside the inhaler until only a moment prior to use, and thus the chances of spillage are greatly reduced.
Because the present invention operates only under the inhalative power of the patient, the inhaler carries the additional advantage that no accessory device, such as a compressed air cylinder or other propellant, needs to be used in conjunction with the present invention.
Another advantage of the present invention is that the medicament has been stored in a sealed, dry environment until just prior to administration. In addition, during inhalation, the medicament is subjected to mixing by a plurality of baffles contained in the device. These features help to ensure that the medicament exiting the inhaler and entering the patient's respiratory system is in the form of a fine dry powder, facilitating medicament deposition in the lungs. In addition, inhalation of finer powders is typically more comfortable for the patient.
Yet another advantage of the apparatus of the present invention is that it is disposable. A patient can simply use the inhaler, and dispose of it. Other steps such as cleaning, refilling and permanently storing are unnecessary.
The present invention is described with reference to the accompanying drawings. In the drawings, like reference numbers indicate identical or functionally similar elements.
a is a cross sectional view along line 3—3 of
b is a cross sectional view along line 3—3 of
Overview
The present invention provides an improved method and apparatus for dispensing dry powder medicaments for inhalation by a patient. As will be described in more detail below, an apparatus of the present invention is an inhaler having a compact and convenient shape. This inhaler contains a single dose of dry powder medicament, and may be disposed of following use by a patient. The inhaler includes features for allowing air to pass into and through the device as a patient inhales. In proper use, air will exit the inhaler carrying a full dose of medicament in the form of a fine, dry powder, with little risk of spillage. Following use, the inhaler may be disposed of.
The methods of the present invention use an inhaler to administer a single dose of dry powder medicament. As will be discussed in greater detail below, a user utilizes the method of the present invention by removing the inhaler from any protective wrapping. The fine powder medicament contained therein is released from a powder chamber and inhaled. The inhaler may then be disposed of.
Inhaler and Associated Method of the Present Invention
An exemplary embodiment of the present invention will now be described. Referring to
As further illustrated in
Referring next to
With reference to
The operation of an inhaler of the present invention will now be described. For convenience, the inhaler 10 of
When provided to a user, such as a patient, the inhaler 10 will preferably appear substantially as shown in
When a patient is prepared to administer a dose of medicament, the patient first removes an inhaler 10 from its carrying case and/or protective wrapper 8. The patient then preferably holds the inhaler 10 substantially parallel to the ground and gently tugs on the tether 17 protruding from the powder outlet opening 13. Referring again to
The inhaler 10 is now ready for use in administering a dosage of medicament. The patient's lips are used to form an airtight seal about the powder outlet opening 13. At this time, a relatively forceful inhalation action by the patient will draw air into the casing 11 of the inhaler 10 through at least one ventilation opening 12. The incoming air is forced through the nozzle 14, causing the air to accelerate as the space through which the air is passing narrows, and aiming the air directly into the dosage of medicament previously sealed in the powder chamber 15. Preferably, the powder medicament used will consist of particles of a very fine and low-density nature. Such particles are highly susceptible to aerolization, i.e. they readily mix with ambient air. The stream of air through the nozzle 14 causes the fine particles of medicament to become airborne, and to begin passing through the exit channels 19 and 21 towards the powder outlet opening 13. As noted above, one or more additional ventilation openings may allow one or more secondary or additional streams of air to enter the inhaler 10. These additional streams act to further mix with the powder medicament to facilitate aerolization of the medicament particles. As the airborne medicament passes through the exit channels 19 and 21 and the space about the powder outlet opening 13, the plurality of baffles 20 acts to break up any remaining clumps of medicament. Breaking up the medicament disperses the particles thereof to a size appropriate for effective respiration into the patient's respiratory tract, and makes inhalation more comfortable for the patient.
Preferably, a full dose of medicament will be administered by a single inhalation action by a patient. However, depending on a size of the dose, a patient's lung capacity generally, and a particular inhalation specifically, further inhalations may be necessary. The inhaler 10, including, for example, casing 11, may be in part or completely formed of a translucent or transparent material, revealing to a user whether a full dosage of medicament has been properly administered. Alternatively, a patient may have to learn through experience how to best self-administer a full dosage. Preferably, inhaler 10 is then properly disposed of. In such a disposable embodiment of the present invention, inhaler 10, including, for example, casing 11, is formed from a biodegradable material. One such biodegradable material is biodegradable plastic. Other suitable biodegradable materials would be apparent to one skilled in the art. Alternatively, reusable inhalers may be used in connection with individually provided medicament packets that would be placed in the powder chamber 15 prior to use. Such medicament packets, for use in reusable and disposable inhalers alike, may be prepared for use in any of a variety of ways. For example, a tether or similar arrangement, as discussed above, may be pulled by a user to release medicament stored in the packet. Alternatively, blister packs may be used. In another embodiment, the inhaler may be adapted with a blade or other puncturing or cutting device that may be manipulated by a patient to open a medicament packet. Further variations will be apparent to one skilled in the art.
In one embodiment of the present invention, inhaler 10, including, for example, casing 11, is formed from a material having a desiccant integral to it to protect against moisture during storage. One such material is, for example, a desiccant plastic. In an alternate embodiment of the present invention, a desiccant 100, as shown in
Referring to
When an inhaler 40 is provided to a patient, it will be in a closed position. As discussed above, the inhaler 40 will preferably be contained in a sealed protective enclosure (not shown), such as a plastic package or wrapper. Preferably,
Referring now to
In the present embodiment, the closed position of the powder chamber 65 is preferably maintained merely by the pressure of the second wall 68 against the first wall 66, so long as the pressure is sufficient to prevent premature escape of the medicament housed within the powder chamber 65. The pressure results from a friction fit between the first casing portion 44 and the second casing portion 46, to which the second wall 68 and the first wall 66 are separately attached. Note that first wall 66 and the second wall 68 may each be attached to either the first casing portion 44 or the second casing portion 46, so long as the first wall 66 and the second wall 68 are attached to portions that are movable with respect to one another. Additional pressure between the first wall 66 and the second wall 68 of the powder chamber 65 may be induced if desired by in any way increasing the friction between the first casing portion 44 and the second casing portion 46, such as through the use of one or more detent portions. Alternatively, the junction between the first wall 66 and the second wall 68 may be provided with a releasable seal. This may be preferred where hermetic sealing of a medicament is a priority. However, such measures will typically be unnecessary since, as noted above, the inhaler 40 is preferably contained in a sealed protective enclosure when it is provided to the patient.
The operation of the inhaler 40 of this embodiment of the present invention will now be described. When a patient is prepared to administer a dose of medicament, the patient first removes the inhaler 40 from its protective wrapper. This arrangement allows a patient to slide the first casing portion 44 relative to the second casing portion 46 to cause the inhaler 40, and therefore the powder chamber 65 contained therein to move from a closed position to an opened position. This is analogous in a sense to the act of tugging the exposed tether 17 as was described with reference to
While various embodiments of the present invention have been described above, it should be understood that they have been presented by way of example only, and not limitation. For example, the present invention is not limited to the physical arrangements or dimensions illustrated or described. Nor is the present invention limited to any particular design or materials of construction. As such, the breadth and scope of the present invention should not be limited to any of the above-described exemplary embodiments, but should be defined only in accordance with the following claims and their equivalents.
This application is a divisional of application Ser. No. 09/637,940 filed Aug. 14, 2000, now abandoned.
Number | Name | Date | Kind |
---|---|---|---|
3635219 | Altounyan et al. | Jan 1972 | A |
3669113 | Altounyan et al. | Jun 1972 | A |
3795244 | Lax et al. | Mar 1974 | A |
3837341 | Bell | Sep 1974 | A |
3888253 | Watt et al. | Jun 1975 | A |
3906950 | Cocozza | Sep 1975 | A |
4013075 | Cocozza | Mar 1977 | A |
4069819 | Valentini et al. | Jan 1978 | A |
4105027 | Lundquist | Aug 1978 | A |
4192309 | Poulsen | Mar 1980 | A |
4240418 | Rosskamp et al. | Dec 1980 | A |
4338931 | Cavazza | Jul 1982 | A |
4841964 | Hurka et al. | Jun 1989 | A |
4846168 | Abiko et al. | Jul 1989 | A |
4860740 | Kirk et al. | Aug 1989 | A |
4889114 | Kladders | Dec 1989 | A |
4995385 | Valentini et al. | Feb 1991 | A |
5042472 | Bunin | Aug 1991 | A |
5152284 | Valentini et al. | Oct 1992 | A |
5239991 | Chawla et al. | Aug 1993 | A |
5239992 | Bougamont et al. | Aug 1993 | A |
5301666 | Lerk et al. | Apr 1994 | A |
5349947 | Newhouse et al. | Sep 1994 | A |
5437271 | Hodson et al. | Aug 1995 | A |
5507281 | Kuhnel et al. | Apr 1996 | A |
5524613 | Haber et al. | Jun 1996 | A |
5533505 | Kallstrand et al. | Jul 1996 | A |
5575280 | Gupte et al. | Nov 1996 | A |
5595175 | Malcher et al. | Jan 1997 | A |
5617845 | Poss et al. | Apr 1997 | A |
5647349 | Ohki et al. | Jul 1997 | A |
5651359 | Bougamont et al. | Jul 1997 | A |
5660169 | Kallstrand et al. | Aug 1997 | A |
5673686 | Villax et al. | Oct 1997 | A |
5685294 | Gupte et al. | Nov 1997 | A |
5699789 | Hendricks | Dec 1997 | A |
5727546 | Clarke et al. | Mar 1998 | A |
5740794 | Smith et al. | Apr 1998 | A |
5785049 | Smith et al. | Jul 1998 | A |
5787881 | Chawla | Aug 1998 | A |
5797391 | Cook et al. | Aug 1998 | A |
5810004 | Ohki et al. | Sep 1998 | A |
5829434 | Ambrosio et al. | Nov 1998 | A |
5860419 | Davies et al. | Jan 1999 | A |
5896855 | Hobbs et al. | Apr 1999 | A |
5918594 | Asking et al. | Jul 1999 | A |
5921237 | Eisele et al. | Jul 1999 | A |
6065472 | Anderson et al. | May 2000 | A |
6092522 | Calvert et al. | Jul 2000 | A |
6098619 | Britto et al. | Aug 2000 | A |
6102035 | Asking et al. | Aug 2000 | A |
6105574 | Jahnsson | Aug 2000 | A |
6116237 | Schultz et al. | Sep 2000 | A |
6116238 | Jackson et al. | Sep 2000 | A |
6119853 | Garrill et al. | Sep 2000 | A |
6142145 | Dagsland et al. | Nov 2000 | A |
6187269 | Lancesseur et al. | Feb 2001 | B1 |
6237590 | Leedom et al. | May 2001 | B1 |
6273085 | Eisele et al. | Aug 2001 | B1 |
6286507 | Jahnsson | Sep 2001 | B1 |
6332461 | Hyppola | Dec 2001 | B1 |
6390291 | Garrill et al. | May 2002 | B1 |
6575160 | Volgyesi | Jun 2003 | B1 |
6732732 | Edwards et al. | May 2004 | B1 |
20030094173 | Burr et al. | May 2003 | A1 |
Number | Date | Country |
---|---|---|
WO 9408552 | Apr 1994 | WO |
WO 0064519 | Nov 2000 | WO |
WO 0107107 | Feb 2001 | WO |
Number | Date | Country | |
---|---|---|---|
20020108611 A1 | Aug 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09637940 | Aug 2000 | US |
Child | 10123319 | US |